Home AdExchanger Talks Podcast: How Bayer Cures Programmatic Headaches

Podcast: How Bayer Cures Programmatic Headaches

SHARE:

AdExchanger Talks is a podcast focused on data-driven marketing. Subscribe here. This episode of AdExchanger Talks is supported by Exponential.

Josh Palau, VP for digital strategy at Bayer Consumer Health, spent years in agency land before going over to “the client.” In this week’s podcast, he describes how moving in-house (he has worked at brands like Comcast and J&J) taught him to focus on the numbers.

“Literally I’m in a sales meeting every morning talking about where the channel mix is going,” Palau says. Being on the inside also means dealing with factors that are invisible to agency partners, like IT constraints and internal politics. “It helped open up my mind about all the things that happen.”

In this episode he talks about the changing rules around media and, especially, data. He cites ongoing concerns around third-party audience data, including accuracy and cost issues. But he’s still a believer.

“The way we’ve tried to position programmatic is really about the data targeting,” Palau says. “I’ve used third-party data throughout my entire career. I’m not negative on that.”

Meanwhile first-party data, often held up as a gold standard, has its own perils. For instance, “The people that come to our websites, are we sure they’re the ones we want? We need to make sure we’re not building lookalike segment around coupon seekers, because that’s a really cheap segment to go get.”

Also in this episode: Brand building in the programmatic age, the persistent appeal of the Duopoly and slow growth of ad budgets.

Must Read

Critics Say The Trade Desk Is Forcing Kokai Adoption, But Apparently It’s Up To Agencies

Is TTD forcing agencies to adopt the new Kokai interface despite claims they can still use the interface of their choice? Here’s what we were able to find out.

Why Big Brand Price Increases Will Flatten Ad Budgets

Product prices and marketing budgets are flip sides of the same coin. But the phase-in effects of tariffs, combined with vicissitudes of global weather and commodity production, challenge that truism.

The IAB Tech Lab Isn’t Pulling Any Punches In The Fight Against AI Scraping

IAB Tech Lab CEO Anthony Katsur didn’t mince his words when declaring unauthorized generative AI scraping of publisher content “theft, full stop.”

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters
Comic: Gamechanger (Google lost the DOJ's search antitrust case)

Here’s Who’s Testifying During The Remedy Phase Of Google’s Ad Tech Antitrust Trial

Last week, the DOJ and Google filed their respective witness lists and the exhibit lists for the remedy phase of the ad tech antitrust trial. Lots of familiar faces!

MX8 Labs Launches With A Plan To Speed Up The Survey-Based Research Biz

What’s the point of a market research survey that could take weeks, when consumer sentiment is rollercoasting up and down every day? That’s the problem MX8 Labs aims to tackle.